期刊文献+

沉默中介体19对人乳腺癌MCF-7细胞侵袭及迁移的影响 被引量:2

Influence of silencing Med19 on metastasis and invasion of human breast cancer MCF-7 cells
下载PDF
导出
摘要 目的:研究中介体19(Med19)对人乳腺癌MCF-7细胞侵袭及迁移的影响。方法:用慢病毒介导的Med19小分子干扰RNA(siRNA)感染人乳腺癌细胞MCF-7(KD组),并设置空载体转染组(NC组)、空白对照组(CON组)。荧光显微镜下观察细胞感染效率,利用RT-PCR和Western blot检测Med19蛋白表达,用划痕实验和transwell实验检测细胞迁移及侵袭能力。结果:荧光显微镜下观察细胞感染慢病毒效率达90%以上。与NC组及CON组细胞相比,KD组Med19 mRNA表达水平下降了72.3%、72.1%,Med19蛋白表达水平下降了85.4%、85.3%,差异均有统计学意义(P<0.05)。分别在0、6、12、24 h比较迁移的距离,KD组细胞随着时间的延长,较CON组、NC组迁移能力显著下降,差异有统计学意义(P<0.05);KD组、NC组、CON组MCF-7细胞穿过聚碳酸酯膜的细胞数分别为23.8±4.32、43.4±3.65、45.8±5.81,KD组较CON组、NC组细胞的侵袭能力显著降低,差异均有统计学意义(P<0.05)。NC组与CON组相比,细胞迁移和侵袭能力差异无统计学意义(P>0.05)。结论:Med19基因沉默抑制细胞的迁移及侵袭能力,从而抑制乳腺癌的恶性生物学行为。 Objective To investigate the influence of silencing Med19 on metastasis and invasion of human breast cancer MCF-7 cells. Methods lentivirus expression vector delivering small hairpin RNA (shRNA) against Med19 gene was constructed, then transfected of human breast cancer MCF-7 cell line. There were three experimental groups: non-infected (CON) group, Lv-NC-infected (NC) group, and Lv-shMed19-infected (KD) group. To determine the lentiviral infection efficiency, expression of GFP was detected with fluorescence microscopy. The mRNA and protein levels of Med19 in three groups MCF-7 cells were detected by real-time PCR and Western blotting. Scratching and transwell tests were employed to determine the ability of metastasis and invasion of cells. Results The highest infection efficiency was obtained, resulting fluorescent expression identified in more than 90% of MCF-7 cells 120 h after infection. The expression of Med19 mRNA in the KD group was dramatically decreased by 72.3% compared with the NC group, and by 72.1% compared with the CON group, respectively (P 〈 0.05). The Med19 protein expression in the KD group was significantly lower than that of the NC group and the CON group, with a reduction of 85.4% and 85.3%, respectively (P 〈 0.05). No statistical significance was detected between the NC groups and the CON groups. Thus, the constructed Lv-shMed19 was demonstrated to be active and specific in inhibiting the expression of Med19. Moreover, the invasive distances of KD group, NC group and CON group MCF-7 cells were compared at 6 hour, 12 hour and 24 hour. The invasive ability of MCF-7 cells decreased significantly with the extension of time (P 〈 0.05). The cells passed through polycarbonate membrane in KD group, NC group and CON group were 23.8 ±4.32, 43.4 ±3.65 and 45.8 ± 5.81 respectively. The metastatic ability of KD group was significant reduced (P 〈 0.05). Conclusion Silencing of Med19 gene significantly decreases the ability of metastasis and invasion of human breast cancer MCF-7 cells, and then suppresses the malignant biological behavior of breast cancer.
出处 《实用医学杂志》 CAS 北大核心 2014年第9期1373-1375,共3页 The Journal of Practical Medicine
基金 无锡市医院管理中心资助项目(编号:YGZXQ1311)
关键词 MED19 慢病毒 乳腺癌细胞 RNA干扰 Med19 Lentivirus Breast cancer cells RNA interference
  • 相关文献

参考文献4

二级参考文献48

  • 1Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangio carcinoma variants. J Gastroenterol Hepatol 2002; 17: 401-5.
  • 2Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005; 9: 191-211.
  • 3EI-Serag HB. Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127:S27-34.
  • 4McKillop IH, Schrum LW. Alcohol and liver cancer. Alcohol 2005; 35: 195-203.
  • 5Farazi PA, De Pinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006; 6: 674-87.
  • 6EIbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-8.
  • 7Fidler U. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Rev Cancer 2003; 3: 453-8.
  • 8Westhof E, Filipowicz W. From RNAi to epigenomes: how RNA rules the world. Chem Biochem 2005; 6: 441-3.
  • 9Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, et al. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol Cell 2004; 14: 685-91.
  • 10Kornberg RD. Mediator and the mechanism of transcriptional activation. Trends Biochem Sci 2005; 30: 235-9.

共引文献15

同被引文献19

  • 1耿长新,曾昭冲,周长宏,王吉耀,亓玉琴.多烯紫杉醇体内对肝癌放化疗及其对p21和bcl-2表达影响[J].世界华人消化杂志,2005,13(24):2848-2852. 被引量:9
  • 2Shaobin Wu,Xianwei Wang,Jinxiang Chen,Yuxiang Chen.Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells[J]. Biochemical and Biophysical Research Communications . 2013 (4)
  • 3Barboule N,Chadebech P,Baldin V,et al.Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line. Oncegene . 1997
  • 4Hata Taishi,Yamamoto Hirofumi,Ngan Chew Yee,Koi Minoru,Takagi Akimitsu,Damdinsuren Bazarragchaa,Yasui Masayoshi,Fujie Yujiro,Matsuzaki Takeshi,Hemmi Hiromichi,Xu Xundi,Kitani Kotaro,Seki Yosuke,Takemasa Ichiro,Ikeda Masataka,Sekimoto Mitsug.Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Molecular Cancer . 2005
  • 5Giannakakou P,Poy G,Zhan Z,Knutsen T,Blagosklonny M V,Fojo T.Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. Oncegene . 2000
  • 6Kelling Jonathan,Sullivan Kevin,Wilson Leslie,Jordan Mary Ann.Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Cancer Research . 2003
  • 7Gang Li,Jingfeng Zhao,Xianjing Peng.Radiation/Paclitaxel Treatment of p53-Abnormal Non-Small Cell Lung Cancer Xenograft Tumor and Associated Mechanism. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS . 2012
  • 8Li-Hua Li,Jie He,Dong Hua.Lentivirus-mediated inhibition of Med19 suppresses growth of breast cancer cells in vitro. CANCER CHEMOTHERAPY AND PHARMACOLOGY . 2011
  • 9Pharoah PD,Day NE,Caldas C.Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. British Journal of Cancer . 1999
  • 10Barroso-Gonzlez J,Thomas G.Endosome traffic machinery meets the p53-p21 axis. Mol Cell Oncol . 2015

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部